Partner Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Partner Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-37,993	Closed	-$2.49M	–	91
2015 Q4	$2.49M	Buy	37,993 +7,801	+26%	+$482K	4.09%	4
2015 Q3	$1.71M	Buy	30,192 +5,051	+20%	+$328K	2.58%	11
2015 Q2	$1.49M	Buy	25,141 +9,832	+64%	+$607K	2.09%	14
2015 Q1	$954K	Sell	15,309 -102,322	-87%	-$5.95M	1.44%	25
2014 Q4	$6.76M	Buy	117,631 +17,192	+17%	+$958K	2.76%	9
2014 Q3	$5.4M	Sell	100,439 -238,646	-70%	-$12.6M	1.97%	23
2014 Q2	$17.8M	Buy	339,085 +28,153	+9%	+$1.44M	3.56%	10
2014 Q1	$16.4M	Buy	+310,932	New	+$14.4M	3.03%	9

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Partner Investment Management's TEVA Position: Q1 2016 in Review

Partner Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 37,993 shares — an estimated $2.49M sold.

Partner Investment Management first reported a position in TEVA in Q1 2014 and held it in 8 quarters. The position peaked at $17.8M in Q2 2014. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Partner Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Partner Investment Management sold 37,993 Teva Pharmaceuticals shares in Q1 2016, an estimated $2.49M.
Partner Investment Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 8 quarters.
Partner Investment Management's Teva Pharmaceuticals position peaked at $17.8M in Q2 2014.
837 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Partner Investment Management's 13F filing for Q1 2016, filed 16 May 2016.